Journey Medical Corporation
DERM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -29.1% | 7.5% | 16.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.8% | 66.3% | 58.2% | 49.2% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -15% | 2.4% | -31.5% | -51.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26.1% | -4.9% | -40.2% | -69.7% |
| EPS Diluted | -0.72 | -0.21 | -1.69 | -2.54 |
| % Growth | -242.9% | 87.6% | 33.5% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |